"Cephamycins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.
| Descriptor ID |
D002513
|
| MeSH Number(s) |
D02.065.589.099.249.250 D02.886.665.074.250 D03.633.100.300.249.250
|
| Concept/Terms |
Cephamycins- Cephamycins
- Antibiotics, Cephamycin
- Cephamycin Antibiotics
|
Below are MeSH descriptors whose meaning is more general than "Cephamycins".
Below are MeSH descriptors whose meaning is more specific than "Cephamycins".
This graph shows the total number of publications written about "Cephamycins" by people in this website by year, and whether "Cephamycins" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Cephamycins" by people in Profiles.
-
Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children. Pediatrics. 1983 Feb; 71(2):187-91.
-
Moxalactam therapy of bacterial meningitis in adults. Antimicrob Agents Chemother. 1983 Feb; 23(2):289-92.
-
Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations. Rev Infect Dis. 1982 Nov-Dec; 4 Suppl:S597-602.
-
Successful moxalactam therapy for gram-negative bacillary meningitis in neonates. South Med J. 1982 May; 75(5):632-3.
-
Use of moxalactam for bacterial meningitis. J Pediatr. 1982 May; 100(5):843.
-
Relapse of Escherichia coli meningitis following therapy with moxalactam. Pediatr Infect Dis. 1982 Jan-Feb; 1(1):24-8.
-
Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. J Pediatr. 1981 Jan; 98(1):152-7.
-
In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin. Antimicrob Agents Chemother. 1980 Mar; 17(3):470-3.